GILEAD SCIENCES, INC. reported grant involving 471,698 shares of ASSEMBLY BIOSCIENCES, INC. at $26.50 for $12.5M on May 26, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
10% owner
10%
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$12,499,997Shares × reported price
Shares traded
471,698Common Stock
Price per share
$26.50Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
4,977,089Direct
Trade date
May 26, 2026Grant
Filed
May 27, 2026, 8:55 PM ET2-day reporting delay
Accession
0001123292-26-000751Code A · Transaction 87709
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ASMB price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ASMB · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.5%1w ago −4.4%1d ago +2.2%
Returns since7d −13%30d −3.6%90d +32%180d1y

Footnotes in full

No footnotes recorded. Check the original SEC filing for the complete report.